Trending News – October 20th, 2022

The Chief Marketing Officer of a prescription digital therapeutics (PDT) company was seeking to prepare the organization for future launches. Read how Vynamic leveraged both Healthcare Technology and Life Sciences expertise to build a detailed, practical launch playbook used to expand commercialization in both products and patient types.

Following the acquisition of a large company, Vynamic’s global biopharmaceutical client needed to integrate the people, processes, and technology from both organizations into a new, unified Commercial Operations group. Read how Vynamic provided the collaborative leadership and deep expertise to successfully combine the organizations through enhanced ways of working and common technologies.

Following an acquisition, a global biopharmaceutical company needed to consolidate disparate brands into a single portfolio and enable a new brands director. Read how Vynamic completed a comprehensive assessment and knowledge transfer to enable the new director to lead the portfolio and implement recommended improvements.

In the midst of integrating one company from a prior deal, a mid-sized pharmaceutical organization made an additional acquisition with a narrow timeframe to complete the integration to meet contractual obligations. Read how Vynamic adapted plans and led a range of activities to meet the original target integration dates despite significant client resource constraints.

Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity, Equity, & Inclusion (DEI) across their local countries with the goal of developing a recommended DEI operating model, strategy, and implementation plan.